The Annual International Symposium on Myeloproliferative Neoplasms

* The program is subject to change without notice.

* Time listed in Taiwan Standard Time.

08:30 – 09:00Registration

09:00 – 09:05

Opening RemarksDr. Wen-Chien Chou
MPN Pathophysiology

09:05 – 09:30

The Role of JAK2V617F Allele Burden in MPNDr. Hsin-An HouDr. Richard Silver
09:30 – 09:55Clinical Phenotype and Prognosis of JAK2 and CALR Mutation in Asian Patients with ETDr. Chin-Hin Ng
09:55 – 10:20JAK2V617F Allele Burden AssayDr. Chih-Cheng Chen
10:20 – 10:35Coffee Break
Interferon in PV
10:35 – 11:00Managing Polycythemia Vera in 2023Dr. Richard SilverDr. Norio Komatsu
Dr. Sung-Yong Kim
11:00 – 11:25Six-year Results of the PROUD/CONTI-PV StudyDr. Jean-Jacques Kiladjian
11:25 – 11:50Efficacy and Safety of Ropeginterferon Alfa-2b Treatment in Japanese Patients with PVDr. Keita Kirito
11:50 – 12:15Molecular Response of Ropeginterferon Alfa-2b in Korea patients with PVDr. Sung-Eun Lee
12:15 – 13:15Lunch
Management of MPNs
13:15 – 13:40Clinical Characteristics of Japanese patients with PV/ETDr. Katsuto TakenakaDr. Chul-Won Choi
Dr. Kazuya Shimoda
13:40 – 14:05Intervention in Prefibrotic and Early Overt MyelofibrosisDr. Abdulraheem Yacoub
14:05 – 14:30Ropeginterferon Alfa-2b in Early MyelofibrosisDr. Gill Harry
14:30 – 14:55Ropeginterferon Alfa-2b in HU Resistant/Intolerant Patient with PVDr. Qian Jiang
14:55 – 15:10Coffee Break
Current and Future Treatments
15:10 – 15:35MPN Updates and the Evolution of the DiseaseDr. Ruben MesaDr. Lee-Yung Shih
Dr. Than Hein
15:35 – 16:00A Paradigm Shift in The Diagnosis and Treatment of MPNs, Sooner Better than Later?Dr. Hans K Hasselbalch
16:00 – 16:25Panel DiscussionDr. Dong-Tsamn Lin
16.25 – 16:30Closing RemarksDr. Wen-Chien Chou